Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

Also called NCT01254552

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 351 participants (enrolled count) (from the registry)
Sponsor
  • Guerbet Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01254552
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01254552. Allocation not applicable; no masking; primary purpose diagnostic. Start 2010-08 (actual); primary completion 2011-09 (actual). Results posted on 2019-05-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
Acronym
ACCREDIT
Condition
Type 2 Diabetes Mellitus
Condition
Coronary Atherosclerosis
Intervention (Drug)
iobitridol
Intervention (Drug)
gadoterate meglumine
Lead sponsor
Guerbet (class: industry)

Record details

Record id
cardio:ct-nct01254552
Content hash
ce7a19b90350161c0d21c4df6e93f1c0e67281868b89c0ac7aa60028f92027e2